39942-49-9

Basic information

• Product Name: 3-Nitro Lidocaine
• Synonyms: 3-Nitro Lidocaine;2-(DiethylaMino)-N-(2,6-diMethyl-3-nitrophenyl)acetaMide;2-DiethylaMino-3'-nitro-2',6'-acetoxylidide;α-DiethylaMino-3-nitro-2,6-diMethylacetanilide
• CAS NO: 39942-49-9
• Molecular Formula: C₁₄H₂₁N₃O₃
• Molecular Weight: 279.33484
• Product Categories: Amines;Aromatics;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals
• Mol File: 39942-49-9.mol
• Article Data: 3

Chemical Properties

• Melting Point: 49-55?C
• Appearance: /
• Storage Temp.: Refrigerator
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 3-Nitro Lidocaine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Nitro Lidocaine(39942-49-9)
• EPA Substance Registry System: 3-Nitro Lidocaine(39942-49-9)

Safety Data

• Hazardous Substances Data: 39942-49-9(Hazardous Substances Data)

Usage

Chemical Properties

Yellow Solid

Uses

3-Nitro Lidocaine ia a Lidocaine analogue.

Upstream product

• 109-89-7 diethylamine 
• 137-58-6 2-diethylamino-N-(2,6-dimethylphenyl)-acetamide 

Downstream Products

• 39942-50-2 N-(3-amino-2,6-dimethylphenyl)-2-(diethylamino)acetamide 
• 848441-68-9 2-diethylamino-N-[2,6-dimethyl-3-(4-phenyl-butylamino)-phenyl]-acetamide 
• 848441-58-7 N-[3-(3-benzyl-ureido)-2,6-dimethyl-phenyl]-2-diethylamino-acetamide 
• 848441-64-5 2-diethylamino-N-[2,6-dimethyl-3-tridecylamino-phenyl]-acetamide 
• 848441-65-6 Z-tetradec-9-enoic acid [3-(2-diethylamino-acetylamino)-2,4-dimethyl-phenyl]-amide 
• 848441-46-3 tetradecanoic acid [3-(2-diethylamino-acetylamino)-2,4-dimethyl-phenyl]-amide 

Relevant articles and documents

NITRATION

The present invention relates to a process for preparing a nitrated compound, comprising the step of reacting a compound (A) comprising at least one substituted or unsubstituted aromatic or heteroaromatic ring, wherein said heteroaromatic ring comprises at least one heteroatom selected from the group consisting of oxygen, sulfur, phosphor, selenium and nitrogen, with a compound of formula (I) wherein Y is selected from the group consisting of hydrogen and nitro.

Lidocaine antigens and antibodies

Derivatives of anesthetics involving anilides, lidocaine being illustrative, are provided, having an annular amino group. A difunctional linking group is provided, which provides a link to the annular amino group and an antigen, with the resulting conjugate being employed for the preparation of antibodies. The antibodies find particular use in competitive protein binding assays. Conjugates to enzymes are prepared which find particular use in homogeneous enzyme immunoassays.